Target RWE
Overview
Health evidence solutions company generating real-world evidence from longitudinal patient registries and curated RWD, with deep therapeutic focus in liver disease, gastroenterology, and dermatology. Provides regulatory-grade analyses for drug development, label expansion, and post-marketing surveillance.
Notable
Its registries capture longitudinal patient journeys across academic and community settings; acquired by Highlander Health in January 2026.
Key services
- disease registries (e.g., TARGET-NASH)
- data abstraction and curation
- regulatory-grade RWE analytics
- post-marketing and pharmacovigilance studies
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Target RWE? Share your experience in a short, confidential interview.
Share your experience